A Gene for Meckel Syndrome Maps to Chromosome 11q13  by Roume, J. et al.
Am. J. Hum. Genet. 63:1095–1101, 1998
1095
A Gene for Meckel Syndrome Maps to Chromosome 11q13
J. Roume,1,2 E. Genin,3 V. Cormier-Daire,1 H. W. Ma,1 B. Mehaye,1 T. Attie,1 F. Razavi-Encha,4
C. Fallet-Bianco,5 A. Buenerd,6 F. Clerget-Darpoux,3 A. Munnich,1 and M. Le Merrer1
1Unite´ de Recherches sur les Handicaps Ge´ne´tiques de l’Enfant, INSERM U. 393, Hoˆpital des Enfants Malades, 2Service d’Histologie-
Embryologie-Cytoge´ne´tique Unite´ d’Embryofoetopathologie, Hoˆpital St. Antoine, 3Unite´ de Recherches d’ Epide´miologie Ge´ne´tique, INSERM
U. 155, and 4Service d’Histologie-Embryologie-Cytoge´ne´tique, Unite´ d’Embryofoetopathologie, Hoˆpital Robert Debre´, Paris; 5Service
d’Anatomo-Pathologie, Hoˆpital Henri Mondor, Creteil, France; and 6Service d’Anatomo-Pathologie, Hoˆpital Edouard Herriot 5, Lyon
Summary
Meckel syndrome (MKS) is a rare autosomal recessive
lethal condition of unknown origin, characterized by (i)
an occipital meningo-encephalocele with (ii) enlarged
kidneys, with multicystic dysplasia and fibrotic changes
in the portal area of the liver and with ductal prolifer-
ation, and (iii) postaxial polydactyly. A gene responsible
for MKS in Finland has been mapped to chromosome
17q21-q24. Studying a subset of Middle Eastern and
northern African MKS families, we have recently ex-
cluded the chromosome 17 region and have suggested
a genetic heterogeneity. In the present study, we report
on the mapping of a second MKS locus (MKS2) to chro-
mosome 11q13, by homozygosity mapping in seven fam-
ilies that do not show linkage to chromosome 17q21-
q24 (maximum LOD score 4.41 at recombination frac-
tion .01). Most interestingly, the affected fetuses of
southern Tunisian ancestry shared a particular haplo-
type at loci D11S911 and D11S906, suggesting that a
founder effect is involved. Our observation gives support
to the clinical and genetic heterogeneity of MKS.
Introduction
Meckel syndrome (MKS [MIM 249000]; Meckel 1822)
is a rare autosomal recessive lethal condition of un-
known origin, characterized by (i) an occipital meningo-
encephalocele with both (ii) enlarged kidneys, with mul-
ticystic dysplasia and fibrotic changes of the liver in the
portal area and with ductal proliferation, and (iii) post-
axial polydactyly (Salonen 1984; Blankenberg et al.
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1987). Intra- and interfamilial clinical variability have
long been recognized in this syndrome (Fraser and Lyt-
wyn 1981; Plauchu et al. 1981; Seller 1981; Moerman
et al. 1993; Wright et al. 1994). Other malformations
frequently include microphthalmia, cleft lip and palate,
bowing of long bones, situs inversus, heart defects, and
genital anomalies.
MKS has a reported incidence of 1/13,250–1/140,000
births. In Finland, its prevalence averages 1/9,000 births
(Salonen and Norio 1984). Recently, a gene responsible
for MKS in Finland has been mapped to chromosome
17q21-q24, with no evidence of either locus heteroge-
neity or linkage disequilibrium in this population (Paa-
vola et al. 1995, 1996a, 1996b). MKS is also relatively
frequent in Maghreb and in the Middle East (Crawford
et al. 1978; Zlotogora 1997).
Studying a subset of Middle Eastern and northern Af-
rican MKS families, we have recently excluded the dis-
ease gene from close vicinity to the Finnish MKS gene
(Roume et al. 1997). In the present report, we show that
homozygosity mapping in affected fetuses harboring se-
vere cerebral anomalies results in the mapping of an
MKS gene to chromosome 11q13 in seven inbred fam-
ilies.
Patients and Methods
Patients
Criteria for inclusion in the study were (1) cystic dys-
plasia of the kidneys, (2) fibrotic changes of the liver,
(3) a distinctive malformation triad of the CNS, and (4)
normal blood or cultured skin fibroblast karyotype. The
CNSmalformation triad included (i) prosencephalic dys-
genesis (arhinencephaly-holoprosencephaly and related
midline anomalies), (ii) occipital exencephalocele, with
extrusion of the diencephalic-rhombencephalic dilated
roof through the posterior fontanelle, and (iii) rhombic
roof dysgenesis with absent brain tectum and agenesis-
dysgenesis of the cerebellar vermis, similar that observed
in the Dandy-Walker anomaly (Hori et al. 1980; Aleksic
et al. 1984; Ahdab-Barmada and Claasen 1990; also see
table 1).
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Table 1
Neuropathological Features of Ahdab-Barmada and Claasen (1990) Malformation Triad in Eight MKS Fetuses
CNS ANOMALY
STATUS (TERM) INa
Family 2
Family 3:
Case III-3
(19 wk)
Family 4:
Case IV-9
(17 wk)
Family 5:
Case V-3
(24 wk)
Family 6:
Case V-1
(23 wk)
Family 7:
Case III-6
(21 wk)
Family 9:
Case IV-1
(25 wk)
Case V-3
(21 wk)
Case V-4
(14 wk)
Prosencephalic abnormalities:        
Anencephaly        
Prosencephalic dysgenesis  0      
Absence of olfactory bulbs  0  0    ND
Fused thalami /hypothalamic hamartoma  0  0  ND ND
Agenesis corpus callosum  0  0    ND
Hypoplasia third ventricle  0     ND ND
Small optic nerves, microphthalmia  ND ND  ND   ND
Microcephaly  0     0 
Occipital exencephalocele        
Rhombic roof abnormalities:  0      
Absent brain tectum  0   ND   
Agenesis/dysgenesis of cerebellar vermis  0  ND ND   
Elongated brain stem  0  ND ND   
Other anomalies:  0  0    
Aqueductal stenosis/dysgenesis 0 0  ND    ND
Migration anomalies  0  0    
Absence/hypoplasia of pyramids ND 0  0 ND   
Medullar and/or bulbar dysgenesis  0  0   ND 
a   Affected,   nonaffected, 0  not conclusive, and ND  not determined.
A total of seven consanguineous families of northern
African and Middle Eastern ancestry were included in
the study: four families (families 2, 5, 6, and 9) were
from Tunisia, one (family 7) was from Algeria, one (fam-
ily 4) was from Senegal, and one (family 3) was from
Pakistan (fig. 1). Pregnancies were terminated during the
second trimester, after ultrasound diagnosis of MKS. Ul-
trasonographic data, karyotype, autopsies, photographs,
and histological specimens were obtained, and a detailed
postmortem examination with thorough neuropatho-
logical evaluation was performed (table 1; also see En-
cha-Razavi 1997; Roume et al. 1997). These studies
were completed with the approval of the institutional
board: Comite´ Consultatif pour la Protection des Per-
sonnes of Necker Enfants Malades Hospital.
DNA Preparation and Genotyping
DNA was extracted, from either frozen tissues or cul-
tured skin fibroblasts of affected fetuses and from lym-
phocyte pellets of their relatives, by SDS lysis, proteinase
K digestion, phenol/chloroform extraction, ethanol pre-
cipitation, and Tris-EDTA resuspension. For genotyping,
microsatellite DNA markers were amplified by 0.5 U of
Taq polymerase (Life Technologies) in a buffer contain-
ing 1.5 mM MgCl2, 20 mM of each deoxynucleotide, 1
mM of each primer, and 200 ng of genomic DNA, in a
final volume of 20 ml. After an initial denaturation step
at 94C for 10 min, PCR was conducted for 30 cycles,
each with a denaturation step at 94C for 30 s, annealing
at 55C for 30 s, and extension at 72C for 30 s. The
reaction was completed with an elongation step at 72C
for 10 min. Amplified products were separated on 6%
polyacrylamide gels run under denaturing conditions
and were transferred onto charged nylon membranes
(Hybond N; Amersham). Membranes were hybridized
overnight at 42C with poly-AC probes, were labeled by
chemiluminescence (ECL [a direct nucleic-acid labeling
and detection system]; Amersham Life Science), and
were exposed to x-ray films for 10 min.
Statistical Analyses
Because all MKS families in the present study were
consanguineous, we performed a genomewide scan
based on the homozygosity-mapping method (Lander
and Botstein 1987). When affected fetuses were found
to be homozygous, the corresponding region was further
studied by first typing the parents and relatives for flank-
ing markers and then computing the pairwise and mul-
tipoint LOD score (Z) values. Genetic distances between
markers were derived from the Ge´ne´thon database (Dib
et al. 1996). Z values were computed by the program
GENEHUNTER (Kruglyak et al. 1996), under the as-
sumption of a fully penetrant autosomal recessive dis-
ease gene (frequency .001). Since the number of alleles
and the allele frequencies were unknown in the various
ancestries, we recoded the marker alleles, allowing for
only four equifrequent alleles in each family. Linkage
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Figure 1 Pedigrees and haplotype analyses in seven nuclear inbred families with the distinctive Ahdab-Barmada and Claasen (1990)
malformation triad of the CNS.
heterogeneity was tested by the admixture test (Smith
1963).
Results
The genomic DNA of eight MKS fetuses belonging to
seven inbred families were studied by means of 250 mi-
crosatellite DNA markers spanning the whole genome
at a genetic distance of ∼10 cM (Dib et al. 1996). Among
them, marker AFM 155xh10 at locus D11S911 on chro-
mosome 11q13 revealed homozygosity in seven of the
eight MKS fetuses. Subsequently, pairwise linkage be-
tween the disease gene and microsatellite DNA markers
of chromosome 11q13 was tested in the seven MKS
families. Genetic distances (in parentheses) in the fol-
lowing sequence of markers markers have been estab-
lished elsewhere: cen–D11S916 (4.1 cM) D11S911 (0.3
cM) D11S906 (1.1 cM) D11S 937 (1.4 cM) D11S918
(1.3 cM) D11S1362–tel (Dib et al. 1996).
The highest pairwise Z (Zmax) values were obtained
for markers AFM 155xh10 and AFM 107xc7, at, re-
spectively, the D11S911 locus (Zmax  4.41 at recom-
bination fraction [v] .01) and the D11S906 locus Zmax
4.13 at v  .01; see table 2). Multipoint linkage analysis
showed that the maximum location score of the disease
gene was at locus D11S911 (location score 4.03; see fig.
2).
Haplotype reconstruction revealed that all MKS fe-
tuses but one (i.e., V-1 in family 6) were homozygotes
at loci D11S906 and D11S911. Interestingly, the affected
fetuses of northern African origin (families 2, 5, 7 and
9) shared the same haplotype at loci D11S911 and
Table 2
Pairwise Z Values between MKS and Six Microsatellite DNA Markers of
Chromosome 11q
LOCUS AND FAMILY
Z AT v a
.00 .01 .05 .10 .20 .30
D11S916 (AFM 185ya1):
2 1.53 1.49 1.33 1.13 .75 .41
3 .72 .70 .60 .48 .27 .13
4  2.26 .98 .46 .06 .06
5 .51 .49 .40 .29 .14 .06
6 2.69 .96 .33 .10 .05 .07
7 .00 .00 .00 .00 .00 .00
9 1.26 .89 .43 .23 .08 .03
Total  1.53 .60 1.12 1.08 .70
D11S911 (AFM 155xh10):
2 1.54 1.50 1.32 1.11 .70 .36
3 .72 .70 .60 .48 .27 .13
4 1.43 1.38 1.21 1.00 .61 .31
5 .47 .45 .35 .24 .10 .03
6 2.71 .98 .34 .12 .04 .06
7 .85 .82 .72 .59 .37 .19
9 .56 .53 .44 .34 .18 .08
Total 2.87 4.41 4.30 3.65 2.27 1.17
D11S906 (AFM 107xc7):
2 1.53 1.49 1.31 1.10 .69 .35
3 .33 .31 .26 .21 .12 .06
4 1.51 1.47 1.29 1.08 .69 .36
5 .51 .49 .40 .29 .14 .06
6 2.71 .98 .34 .12 .04 .06
7 .85 .82 .72 .59 .37 .19
9 .56 .53 .44 .34 .18 .08
Total 2.58 4.13 4.08 3.50 2.23 1.16
D11S937 (AFM 256zb5):
2 .02 .19 .44 .50 .41 .23
3 .72 .70 .60 .48 .27 .13
4 1.43 1.38 1.21 1.00 .61 .31
5 .47 .45 .35 .24 .10 .03
6 2.69 .96 .33 .10 .05 .07
7 1.65 .95 .39 .18 .04 .00
9 1.28 .84 .36 .17 .05 .01
Total 2.98 .04 1.51 1.77 1.35 .76
D11S918 (AFM 203vg1):
2 1.23 1.19 1.04 .87 .55 .28
3 .33 .31 .26 .21 .12 .06
4  .31 .24 .35 .31 .20
5 .17 .15 .09 .03 .01 .01
6 3.21 .94 .31 .09 .05 .07
7 2.25 1.52 .86 .54 .23 .09
9 1.28 .86 .38 .18 .05 .01
Total  1.97 .09 .64 .64 .49
D11S1362 (AFM 132xh9):
2 1.23 1.19 1.04 .87 .55 .28
3 .72 .70 .60 .48 .27 .13
4  .31 .24 .35 .31 .20
5 .51 .49 .40 .29 .14 .06
6 .75 .73 .64 .53 .34 .18
7 2.02 1.19 .59 .35 .15 .08
9 1.28 .86 .38 .18 .05 .01
Total   .75 1.95 1.99 1.47 .76
a Because of rounding error, the sums of the entries in some columns do not exactly
match the totals shown.
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Figure 2 Multipoint-Z analysis of MKS2. Family 6 has been excluded.
D11S906, and the two families originating from Tata-
ouine in southern Tunisia (families 2 and 5) shared a
larger common region, encompassing loci D11S916,
D11S911, and D11S906 (fig. 1).
A heterogeneity test was performed at each locus (in-
crement distance 0.1 cM) in the interval defined by loci
D11S916 and D11S1362 and was found to be signifi-
cantly positive ( , with the test’s one-sided na-P  .0135
ture being taken into account; Ott 1985, p. 116). The
estimated proportion of families with linkage was .76.
Rejection of homogeneity was mainly contributed by
family 6, since, in this family, for the whole setZ ! 2
of markers, which excludes linkage to the region. In this
family, the affected fetus was not homozygous for any
of the markers of chromosome 11q13. Exclusion of fam-
ily 6 maximized the location score at locus D11S911
(Zmax  6.09; see fig. 2).
Discussion
Here we have reported the mapping of a second MKS
locus, MKS2, to chromosome 11q13, by homozygosity
mapping in consanguineous families of northern African
and Middle Eastern origin—families that do not show
linkage to chromosome 17q21-q24 and whose affected
fetuses share a common malformation of the CNS.Most
interestingly, the affected fetuses of northern African an-
cestry shared a particular haplotype at loci D11S911 and
D11S906, suggesting that a founder effect is involved.
Since, in a previous investigation (Paavola et al. 1995),
MKS1 had been mapped to chromosome 17, our ob-
servation in the present study gives support to the clinical
and genetic heterogeneity of MKS (Roume et al. 1997).
In addition, exclusion of chromosomes 11q13 and
17q21-q24 in family 6 suggests the existence of at least
one other disease-causing gene in MKS. Studying fam-
ilies of Middle Eastern and European ancestry, Paavola
et al. (1997) have also provided evidence of genetic het-
erogeneity of MKS. However, in that study, one case
survived (which is unusual in MKS), two fetuses were
not autopsied, and, apart from occipital encephalocele,
no information regarding brain malformations was
available on the other three affected fetuses.
The clinical delineation of MKS has long been con-
fusing, and many authors have previously called atten-
tion to the number of ambiguous and overlapping
cerebro-acro-visceral syndromes (Mecke and Passarge
1971; Seller 1981; Hunter et al. 1991; Lurie et al. 1991;
Walpole et al. 1991; Verloes et al. 1991; Genuardi et al.
1993). Thus, it is possible that quantitative phenotypic
differences in either cerebral changes or other clinical
features could account for the genetic heterogeneity of
MKS (Paavola et al. 1997; Roume et al. 1997). The
mapping of a new disease locus, MKS2, to chromosome
11q13 in a subset of fetuses harboring the severe cerebral
phenotype first described by Ahdab-Barmada and Claa-
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sen (1990) gives strong support to this view. It is inter-
esting to note that the D11S911-D11S906 interval en-
compassing the disease gene also encompasses Phox2a
(Merscher et al. 1997), a gene strongly expressed in the
hindbrain mouse (Pattyn et al. 1997). Ongoing research
directed toward the goal of identifying the disease-caus-
ing genes will, it is hoped, help to resolve the complexity
of MKS phenotypes.
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